Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
+17.9M
-
Total reported value, excl. options
-
$289M
-
Value change
-
+$289M
-
Number of buys
-
54
-
Price
-
$16.10
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2018
54 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q3 2018.
Replimune Group, Inc. - COMMON STOCK (REPL) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 78.4M outstanding shares and own 22.87% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.1M shares), Bain Capital Life Sciences Investors, LLC (2.84M shares), Redmile Group, LLC (2.19M shares), Foresite Capital Management IV, LLC (1.23M shares), BVF INC/IL (912K shares), Foresite Capital Management III, LLC (780K shares), EMERALD ADVISERS INC/PA (618K shares), EMERALD MUTUAL FUND ADVISERS TRUST (523K shares), FMR LLC (483K shares), and Cormorant Asset Management, LP (468K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.